Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group.

DJ, Lovell; CB, Lindsley; RM, Rennebohm; SH, Ballinger; SL, Bowyer; EH, Giannini; JE, Hicks; JE, Levinson; R, Mier; LM, Pachman; MH, Passo; MD, Perez; AM, Reed; KN, Schikler; M, Smith; LS, Zemel; LG, Rider

doi:10.1002/1529-0131(199910)42:10<2213::aid-anr25>3.0.co;2-8

Public

Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group.

Shared by NobleBlocks on Oct 1, 1999 • 12:00 AM UTC

Authors:

Lovell DJ

Lindsley CB

Rennebohm RM

Abstract

Objective To develop, validate, and determine the measurement characteristics of a quantitative tool for assessing the severity of muscle involvement in children with idiopathic inflammatory myopathies.Methods The Childhood Myositis Assessment Scale (CMAS) was developed from 2 existing observational...

Discussions